ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

AVXL Anavex Life Sciences Corporation

3,44
0,05 (1,47%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Anavex Life Sciences Corporation AVXL NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,05 1,47% 3,44 20:48:08
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
3,40 3,37 3,48 3,44 3,39
mais cotações »

Notícias Recentes

Data Hora Fonte Título
26/04/202406:45PRNUSMay 13, 2024 Deadline: Contact The Gross Law Firm to Join..
19/04/202406:45PRNUSContact The Gross Law Firm by May 13, 2024 Deadline to Join..
16/04/202406:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
12/04/202406:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
11/04/202408:30GLOBEAnavex Life Sciences to Present at the Noble Capital Markets..
09/04/202406:45PRNUSClass Action Filed Against Anavex Life Sciences Corporation..
05/04/202406:45PRNUSAnavex Life Sciences Corporation Class Action: The Gross Law..
02/04/202406:45PRNUSShareholders that lost money on Anavex Life Sciences..
29/03/202406:45PRNUSLost Money on Anavex Life Sciences Corporation(AVXL)? Join..
26/03/202406:45PRNUSInvestors who lost money on Anavex Life Sciences..
25/03/202408:30GLOBEAnavex Life Sciences to Present at the 23rd Annual Needham..
22/03/202406:45PRNUSAVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life..
18/03/202408:30GLOBEAnavex Life Sciences Initiates Placebo-Controlled U.S. Phase..
26/02/202409:30GLOBEAnavex Life Sciences to Present at the 44th Annual TD Cowen..
07/02/202409:30GLOBEAnavex Life Sciences Reports Fiscal 2024 First Quarter..
01/02/202409:30GLOBEAnavex Life Sciences to Announce Fiscal 2024 First Quarter..
24/01/202409:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
16/01/202409:30GLOBEAnavex Life Sciences Announces U.S. Phase 2 Clinical Trial..
08/01/202409:30GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
03/01/202409:30GLOBEAnavex to Present at the 42nd Annual J.P. Morgan Healthcare..
02/01/202410:00GLOBEAnavex Life Sciences Provides an Update on Rett Syndrome..
20/12/202309:30GLOBEAnavex Announces First Entire Clinical Gene Pathway Data of..
19/12/202309:30GLOBEAnavex Received Agreement from the Committee for Medicinal..
27/11/202310:00GLOBEAnavex Life Sciences Reports Fiscal 2023 Year End Financial..
27/11/202308:29IHMARKETNEWSMonday’s Wall Street Highlights: Walmart, Disney, Lloyds..
24/11/202310:00GLOBEAnavex Life Sciences to Announce Fiscal 2023 Year End..
22/11/202310:00GLOBEAnavex Life Sciences Announces Grant of U.S. Patent Covering..
20/11/202310:00GLOBEAnavex Initiates Regulatory Submission of Oral Blarcamesine..
06/11/202310:00GLOBEAnavex Life Sciences Appoints Senior VP of Regulatory..
25/10/202309:00GLOBEAnavex Life Sciences Reports New Publication in Scientific..
14/09/202308:30GLOBEAnavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in..
12/09/202308:30GLOBEAnavex Announces Appointment of Dr. Marwan N Sabbagh, MD as..
08/08/202308:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Third Quarter..
07/08/202308:30GLOBEAnavex Life Sciences Reports Publication of ANAVEX®3-71 in..
02/08/202308:30GLOBEAnavex Life Sciences to Present at the BTIG Virtual..
01/08/202308:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Third Quarter..
28/06/202308:30GLOBELong-term Clinical Study Demonstrates Disease Modifying..
27/06/202308:30GLOBEAnavex Life Sciences and Partex Group Announce Strategic..
20/06/202308:30GLOBEAnavex Life Sciences to Present at the H.C. Wainwright 4th..
15/06/202308:30GLOBEANAVEX®2-73 (blarcamesine) Receives Compassionate Use..
12/06/202308:30GLOBEAnavex Life Sciences Reports Publication in Medical Journal..
06/06/202308:30GLOBEAnavex Life Sciences Announces Completion of ANAVEX(®)2-73..
01/06/202308:30GLOBEANAVEX Announces Issuance of New U.S. Intellectual Property..
09/05/202308:30GLOBEAnavex Life Sciences Reports Fiscal 2023 Second Quarter..
02/05/202308:30GLOBEAnavex Life Sciences to Announce Fiscal 2023 Second Quarter..
01/05/202308:30GLOBEAnavex Life Sciences Announces Issuance of New U.S. Patent..

Seu Histórico Recente

Delayed Upgrade Clock